Compagnie Lombard Odier SCmA’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-149,864
| Closed | -$14.6M | – | 684 |
|
|
2021
Q1 | $14.6M | Buy |
+149,864
| New | +$14.6M | 0.32% | 64 |
|
|
2017
Q2 | – | Sell |
-260
| Closed | -$11K | – | 726 |
|
|
2017
Q1 | $11K | Hold |
260
| – | – | ﹤0.01% | 663 |
|
|
2016
Q4 | $10K | Hold |
260
| – | – | ﹤0.01% | 748 |
|
|
2016
Q3 | $13K | Hold |
260
| – | – | ﹤0.01% | 822 |
|
|
2016
Q2 | $12K | Hold |
260
| – | – | ﹤0.01% | 816 |
|
|
2016
Q1 | $10K | Buy |
+260
| New | +$10K | ﹤0.01% | 881 |
|
|
2014
Q1 | – | Sell |
-3,980
| Closed | -$37K | – | 890 |
|
|
2013
Q4 | $37K | Buy |
+3,980
| New | +$37K | ﹤0.01% | 730 |
|